Isolated polycystic liver disease genes define effectors of polycystin-1 function
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Dominantly inherited isolated polycystic liver disease (PCLD) consists of liver cysts that are radiologically and pathologically identical to those seen in autosomal dominant polycystic kidney disease, but without clinically relevant kidney cysts. The causative genes are known for fewer than 40% of PCLD index cases. Here, we have used whole exome sequencing in a discovery cohort of 102 unrelated patients who were excluded for mutations in the 2 most common PCLD genes, PRKCSH and SEC63, to identify heterozygous loss-of-function mutations in 3 additional genes, ALG8, GANAB, and SEC61B. Similarly to PRKCSH and SEC63, these genes encode proteins that are integral to the protein biogenesis pathway in the endoplasmic reticulum. We inactivated these candidate genes in cell line models to show that loss of function of each results in defective maturation and trafficking of polycystin-1, the central determinant of cyst pathogenesis. Despite acting in a common pathway, each PCLD gene product demonstrated distinct effects on polycystin-1 biogenesis. We also found enrichment on a genome-wide basis of heterozygous mutations in the autosomal recessive polycystic kidney disease gene PKHD1, indicating that adult PKHD1 carriers can present with clinical PCLD. These findings define genetic and biochemical modulators of polycystin-1 function and provide a more complete definition of the spectrum of dominant human polycystic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Once OST catalyzes the attachment of the glycan moiety to asparagine residues, first, GI removes the outermost glucose residue, and then GII removes the second one, as expected [433].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [433]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, mutations in SEC63 and PRKCSH are known to cause PCLD, also reducing directly the working dosage of PC1 in the bile duct and kidney tubules cells [433].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [433]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, SEC63 and ERdj1 act in relation to chaperone BiP, facilitating this translocation process.”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [433]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Once OST catalyzes the attachment of the glycan moiety to asparagine residues, first, GI removes the outermost glucose residue, and then GII removes the second one, as expected [433].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [433]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, the loss of Sec61b, Sec63 and PRKCSH results in a severe deficiency of PC1; Alg8 knockout causes the hypoglycosylation of PC1; GANAB knockout results in a defective glucose trimming of N-glycan moieties, resulting in increased apparent molecular mass for PC1 [433].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [433]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Browning, S. R., & Browning, B. L. (2007) · The American Journal of Human Genetics · doi:10.1086/521987 · Cited by 3,210
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
Self-citation
Cited by
Items 101–200 of 217
Emerging treatments and personalised medicine for ciliopathies associated with cystic kidney disease
Molinari, E., & Sayer, J. A. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1372282 · Cited by 12
Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry
Delbarba, E., Econimo, L., Dordoni, C., Martin, E., Mazza, C., Savoldi, G., Alberici, F., Scolari, F., & Izzi, C. (2021) · Journal of Nephrology · doi:10.1007/s40620-021-01131-w · Cited by 12
Association of a novel PKHD1 mutation in a family with autosomal dominant polycystic liver disease
Wang, J., Yang, H., Guo, R., Sang, X., & Mao, Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-3318 · Cited by 12
Schönauer, R. A.-R., Sierks, D., Boerrigter, M. M., Jawaid, T., Caroff, L., Audrézet, M., Friedrich, A., Shaw, M. M., Degenhardt, J., Forberger, M., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.12.007 · Cited by 10
Self-citationJung, M., & Zimmermann, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814166 · Cited by 10
A SEC61A1 variant is associated with autosomal dominant polycystic liver disease
Schlevogt, B., Schlieper, V., Krader, J., Schröter, R., Wagner, T., Weiand, M., Zibert, A., Schmidt, H., Bergmann, C., Nedvetsky, P. I., et al. (2022) · Liver International · doi:10.1111/liv.15493 · Cited by 10
Genetic testing in autosomal dominant polycystic kidney disease: why it matters in 2025
Gall, É. C.-L., & Ong, A. C. M. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf331 · Cited by 10
Challenging Disease Ontology by Instances of Atypical PKHD1 and PKD1 Genetics
de Fallois, J., Schönauer, R. A.-R., Münch, J., Nagel, M., Popp, B., & Halbritter, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.682565 · Cited by 9
Identified eleven exon variants in PKD1 and PKD2 genes that altered RNA splicing by minigene assay
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · BMC Genomics · doi:10.1186/s12864-023-09444-9 · Cited by 9
Molecular Mechanisms of Isolated Polycystic Liver Diseases
Yu, Z., Shen, X., Hu, C., Zeng, J., Wang, A., & Chen, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.846877 · Cited by 9
How Does ADPKD Severity Differ Between Family Members?
Yeung, K., Fryml, E. M., & Lanktree, M. B. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.01.053 · Cited by 9
Roy, S. G., Li, Z., Guo, Z., Long, K. T., Rehrl, S., Tian, X., Dong, K., & Besse, W. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000164 · Cited by 9
Self-citationXu, W., Cui, Y., Chen, L., Ding, K., Ding, C., Chen, F., Zhang, X., & Xie, W. (2021) · The Journal of Pathology · doi:10.1002/path.5636 · Cited by 9
Busch, T., Neubauer, B., Schmitt, L., Cascante, I., Knoblich, L., Wegehaupt, O., Schöler, F., Tholen, S., Hofherr, A., Schell, C., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202401763r · Cited by 8
Ha, K., Loeb, G. B., Park, M., Gupta, M., Akiyama, Y., Argiris, J., Pinedo, A., Park, C. H., Brandes, N., Ritu, F., et al. (2026) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000001008 · Cited by 8
Predominant Liver Cystic Disease in a New Heterozygotic PKHD1 Variant: A Case Report
Buren, J. D. V., Neuman, J. T., & Sidlow, R. (2023) · American Journal of Case Reports · doi:10.12659/ajcr.938507 · Cited by 8
Wang, L. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s332945 · Cited by 8
Kamiya, A., Chikada, H., Ida, K., Ando, E., Tsuruya, K., Kagawa, T., & Inagaki, Y. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.08.018 · Cited by 8
Lee, P. Y., Olaizola, P., Caballero-Camino, F. J., Izquierdo‐Sánchez, L., Rodrigues, P. M., Perugorria, M. J., Azkargorta, M., Elortza, F., Martínez‐Chantar, M. L., Aspichueta, P., et al. (2021) · United European Gastroenterology Journal · doi:10.1002/ueg2.12126 · Cited by 8
Bi, J., Guo, W., Ji, P., Li, S., Wang, P., Li, Q., & Xie, Y. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf064 · Cited by 8
Zhu, J., Liu, F., & Mao, J. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2282027 · Cited by 8
Xin, J., Yin, K., Li, S., Gu, P., & Shao, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1580086 · Cited by 7
Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease
Boerrigter, M. M., Duijzer, R., Morsche, R. H. M. T., & Drenth, J. P. H. (2023) · Genes · doi:10.3390/genes14091755 · Cited by 6
The ER Protein Translocation Channel Subunit Sbh1 Controls Virulence of Cryptococcus neoformans
Santiago-Tirado, F. H., Hurtaux, T., Geddes‐McAlister, J., Nguyen, D. Q., Helms, V., Doering, T. L., & Römisch, K. (2023) · mBio · doi:10.1128/mbio.03384-22 · Cited by 6
Rahbari-Oskoui, F. F., Mrug, M. M., Saigusa, T., & Rizk, D. V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-812534-2.00005-9 · Cited by 6
Polycystic liver disease with lethal abdominal wall rupture: a case report
Akuzawa, D., Uchida, Y., Ishimura, T., Kakita, H., Endo, T., Matsuzaki, N., Terajima, H., & Tsukamoto, T. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-021-02964-6 · Cited by 6
Imaging of fibropolycystic liver disease
Sharbidre, K., Zahid, M., Venkatesh, S. K., Bhati, C. S., & Lalwani, N. (2022) · Abdominal Radiology · doi:10.1007/s00261-022-03565-7 · Cited by 6
Abdelwahed, M., Hilbert, P., Ahmed, A., Dey, M., Bouomrani, S., Kamoun, H., Keskes, L., & Belguith, N. (2022) · Gene · doi:10.1016/j.gene.2021.146174 · Cited by 5
Extrarenal Manifestations: Polycystic Liver Disease and Its Complications
Bugazia, S., & Hogan, M. C. (2023) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2023.10.004 · Cited by 5
Exquisite sensitivity of Polycystin-1 to H2O2 concentration in the endoplasmic reticulum
Speranza, E. A., Sorrentino, I., Boletta, A., & Sitia, R. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103486 · Cited by 5
Novel Treatments for Polycystic Kidney Disease
Patil, A., Sweeney, W. E., Pan, C. G., & Avner, E. D. (2019) · Translational Science of Rare Diseases · doi:10.3233/trd-190040 · Cited by 5
Polycystic kidney disease: new knowledge and future promises
Foo, J. N., & Xia, Y. F. (2019) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2019.06.007 · Cited by 5
Comparative analysis of SEC61A1 mutant R236C in two patient-derived cellular platforms
Weiand, M., Sandfort, V., Nadzemova, O., Schierwagen, R., Trebicka, J., Schlevogt, B., Kabar, I., Schmidt, H., & Zibert, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-59033-3 · Cited by 5
Type IV choledochal cyst with polycystic kidney disease: a case report
He, Y., Yu, Z., & Chen, W. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01445-2 · Cited by 5
A new epitope-tagged Pkhd1 allele sheds light on fibrocystin signaling
Lea, W., & Ward, C. J. (2017) · Kidney International · doi:10.1016/j.kint.2017.05.026 · Cited by 5
DNAJB11 Mutation in ADPKD Patients: Clinical Characteristics in a Monocentric Cohort
Aiello, V., Ciurli, F., Conti, A., Cristalli, C. P., Lerario, S., Montanari, F., Sciascia, N., Vischini, G., Fabbrizio, B., Costanzo, R. D., et al. (2023) · Genes · doi:10.3390/genes15010003 · Cited by 4
Autosomal Dominant Polycystic Kidney Disease
Somlo, S., Torres, V. E., & Caplan, M. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00080-x · Cited by 4
Self-citationPolycystic liver disease: an overview of clinical manifestations, diagnosis, and treatment
Jeong, J., & Park, H. J. (2023) · Kosin Medical Journal · doi:10.7180/kmj.23.128 · Cited by 4
Ellis, J. L., Evason, K. J., Zhang, C., Fourman, M. N., Liu, J., Ninov, N., Delous, M., Vanhollebeke, B., Fiddes, I. T., Otis, J. P., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.2038 · Cited by 4
Preval, K. M., Smith, A. O., & Pazour, G. J. (2025) · Journal of Cellular Signaling · doi:10.33696/signaling.6.144 · Cited by 4
Novel α-1,3-Glucosyltransferase Variants and Their Broad Clinical Polycystic Liver Disease Spectrum
Boerrigter, M. M., Morsche, R. H. M. T., Venselaar, H., Pastoors, N., Geerts, A. M., Hoorens, A., & Drenth, J. P. H. (2023) · Genes · doi:10.3390/genes14081652 · Cited by 3
Advances in genetic, epigenetic and environmental aspects of rare liver diseases
Andersson, E. R., & Lohse, A. W. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104411 · Cited by 3
Hou, Y. C., Yu, H., Martin, R., Schenker-Ahmed, N. M., Hicks, M. A., Cirulli, E. T., Cohen, I. V., Jönsson, T. J., Heister, R., Napier, L. A., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/497560 · Cited by 3
Elhassan, E. A. E., O’Donoghue, D., Heneghan, S., Teltsh, O., Sarihan, S., Osman, S. M., Clince, M., Synnott, D., Craig, S., Hudson, A., et al. (2025) · Journal of Nephrology · doi:10.1007/s40620-024-02184-3 · Cited by 3
Righini, M., Corsi, C., Sciascia, N., Aiello, V., Ciurli, F., Lerario, S., Berti, G. M., Montanari, F., Conti, A., Cristalli, C. P., et al. (2025) · Journal of Nephrology · doi:10.1007/s40620-024-02181-6 · Cited by 3
Ma, D., Cho, S., Meng, X., Gulati, A., Knight, J., Goralsky, L., Peng, G., SHAW, M., Widomski, A., Popa, A., et al. (2026) · Genetics in Medicine · doi:10.1016/j.gim.2026.102529 · Cited by 3
Self-citationBergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_13 · Cited by 3
Yan, Z., Wang, Y., Deng, W., Zhou, Y., Hu, Y., Qi, K., Liu, D., Xia, R., Liu, R., Zeng, W., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.934463 · Cited by 3
Sbh1/Sec61β is a specific signal peptide receptor within the Sec61 channel
Yadhanapudi, L., Lommel, M., Bhadra, P., Barbieri, G., Singh, R., Jung, M., Helms, V., Eisgruber, T., Stengel, F., Boergel, A., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113763 · Cited by 3
Paolis, E. D., Raspaglio, G., Ciferri, N., Zangrilli, I., Tenore, C. R., Urbani, A., Ferraro, P. M., Minucci, A., & Concolino, P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164682 · Cited by 2
Expression of ALG8 in hepatocellular carcinoma and its diagnostic and prognostic significance
Haishen, Y., Jiang, F., Si, X., Sun, D., Fei, H., Wang, D., Li, K., Du, S., Hu, W., & Wang, Z. (2024) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2024.2433562 · Cited by 2
Meng, L., Fang, Z., Jiang, L., Zheng, Y., Hong, S., Deng, Y., & Xie, L. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03557-y · Cited by 2
Germino, G. G., & Guay‐Woodford, L. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00048-6 · Cited by 2
Waddell, S. H., Yao, Y., Olaizola, P., Jarman, E. J., Gournopanos, K., Christodoulou, E., Gautier, P. E., Drenth, J. P. H., Kendall, T. J., Bañales, J. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.08.487546 · Cited by 1
Ishigami, D., Namba, S., Miyawaki, S., Mitsui, J., Imai, H., Shimizu, M., Hongo, H., Dofuku, S., Torazawa, S., Teranishi, Y., et al. (2026) · European Journal of Human Genetics · doi:10.1038/s41431-026-02030-z · Cited by 1
Zhang, X., Wu, J., Zhou, J., Liang, J., Han, Y., Qi, Y., Zhu, T., Yuan, D., Zhu, Z., & Zhai, J. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1429336 · Cited by 1
Genetic Analysis of Severe Polycystic Liver Disease in Japan
Mizuno, H., Besse, W., Sekine, A., Long, K. T., Kurihara, S., Oba, Y., Yamanouchi, M., Hasegawa, E., Suwabe, T., Sawa, N., et al. (2024) · Kidney360 · doi:10.34067/kid.0000000000000461 · Cited by 1
Self-citationBhuva, M., Thompson, E., Watson, C. M., Sava, F., & Griffiths, W. J. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-10072-y · Cited by 1
Varughese, S., Huang, M., & Savige, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0348109 · Cited by 1
Gall, É. C.-L., & Harris, P. C. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7784-0_1 · Cited by 1
Therapies for Childhood Polycystic Kidney Disease
Patil, A., Sweeney, W. E., & Avner, E. D. (2018) · OBM Genetics · doi:10.21926/obm.genet.1804056 · Cited by 1
Polycystic liver diseases: from molecular basis to the development of effective treatments
Markaide, E., Bañales, J. M., & Rodrigues, P. M. (2023) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2023.9649/2023 · Cited by 1
TRP channels in renal disease. Lessons from Polycystin-2 (TRPP2)
Cantero, M. D. R., & Cantiello, H. F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18653-0.00013-7 · Cited by 1
New Ways of Finding New Genes for Old Diseases
Sandford, R. N. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019090940 · Cited by 1
Rules of Engagement for Components of Membrane Protein Biogenesis at the Human Endoplasmic Reticulum
Zimmermann, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188823 · Cited by 1
Elbanna, W. S. S., Azmy, O. M., & Elhinnawi, M. A. (2025) · Cureus · doi:10.7759/cureus.95728 · Cited by 1
Cystic diseases of the liver and biliary tract
Buxbaum, J. L., & Lu, S. C.-L. (2022) · Wiley eBooks · doi:10.1002/9781119600206.ch83 · Cited by 1
Clinical guidance for polycystic liver disease
Barten, T. R. M. (2023) · Radboud University Press eBooks · doi:10.54195/9789493296275
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714158
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714149
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714161
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714146
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714155
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714167
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714143
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714152
Liu, X., Shi, X., Xin, Q., Liu, Z., Pan, F., Qiao, D., Chen, M., Zhang, Y., Guo, W., Li, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23714164
Brossart, K., Curry, K., Punj, S., Darwish, T., & Tabriziani, H. (2026) · Clinical Case Reports · doi:10.1002/ccr3.71994
Ursu, R., Buchholz, B., & Skoczynski, K. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00222.2026
The instructive scar – the dynamic role of extracellular matrix in biliary pathophysiology
Waddell, S. H., Brennan, E., & Boulter, L. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052835
Generation of ADPKD in vitro models for genotype-phenotype correlation and drug discovery
Scarlat, A. (2024) · theses.fr (ABES) · doi:10.70675/f7abe2d0zf681z4f39zab08z8f4ecec624ce
Additional file 1 of Novel GANAB variants associated with polycystic liver disease
van de Laarschot, L. F. M., te Morsche, R. H. M., Hoischen, A., Venselaar, H., Roelofs, H. M. J., Cnossen, W. R., Banales, J. M., Roepman, R., & Drenth, J. P. H. (2020) · Figshare · doi:10.6084/m9.figshare.13142393
Additional file 3 of Novel GANAB variants associated with polycystic liver disease
van de Laarschot, L. F. M., te Morsche, R. H. M., Hoischen, A., Venselaar, H., Roelofs, H. M. J., Cnossen, W. R., Banales, J. M., Roepman, R., & Drenth, J. P. H. (2020) · Figshare · doi:10.6084/m9.figshare.13142399
Ortega-Macías, A. G., Gupta, U., Gil, T. E., Memon, J., & García, P. (2026) · Cureus · doi:10.7759/cureus.105104
Delgado, D. Y. M., Zúñiga-Hernández, L. F., Barrios-Bermúdez, H., Velasco-Erira, S., Díaz‐Brochero, C., & Quintero, C. Y. S. (2026) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2026.103633
Atypical Polycystic Kidney Disease in Individuals Heterozygous for ALG8 Protein-truncating variantsPreprint
Apple, B. J., Sartori, G., Moore, B. S., Chintam, K., Singh, G., Mohan, P., Strande, N. T., Mirshahi, T., Triffo, W. J., & Chang, A. R. (2022) · medRxiv · doi:10.1101/2022.07.13.22277451
Fierbinteanu-Braticevici, C. G., & Moldoveanu, A. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-24432-3_20
Molinari, E., Srivastava, S., Dewhurst, R. M., & Sayer, J. A. (2020) · Figshare · doi:10.6084/m9.figshare.13100986
Faini, A. C., Calleri, A., Pinon, M., Chiadò, C., Calvo, P. L., Vaisitti, T., & Deaglio, S. (2026) · Livers · doi:10.3390/livers6020029
Primary cilia: sensors of biliary homeostasis and disease
Esser, H., & Ferreira-González, S. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01262-0
Hu, C., Xin, Z., Sun, X., Hu, Y., Zhang, C., Yan, R., Wang, Y., Lu, M., Huang, J., Du, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22724243
Congenital Cystic Lesions of the Biliary Tree
Lasagni, A., Morana, G., Strazzabosco, M., Fabris, L., & Cadamuro, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-65908-0_2
Onuchic, L., Padovano, V., Schena, G., Rajendran, V., Dong, K., Gresko, N., Shi, X., Shen, H., Somlo, S., & Caplan, M. J. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3996404
Self-citationPolycystic Kidney Diseases in Adults
Zhou, J. X., & Torres, V. E. (2023) · Nephrology Self-Assessment Program · doi:10.58483/nsap.00112023
Self-citationDebeh, F. G. M., Antoun, M. T. B., Ghanem, A., Rangarajan, V., Borghol, A. H., Paul, S., Hanna, D., Alkhatib, B., Nader, N., Shami, B., et al. (2026) · The Nephron journals/Nephron journals · doi:10.1159/000551274
Autosomal dominant polycystic kidney disease: Current perspectives in 2026
Pichette, M., Park, M., & Gall, É. C.-L. (2026) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2026.05.003
Maladies kystiques hépatorénales héréditaires
Buia, G., & Gall, É. C.-L. (2026) · Encyclopédie médico-chirurgicale. Néphrologie · doi:10.1016/s1762-0945(26)48437-5
Mechanism underpinning the immunosuppressive effects of the mycobacterial macrolide mycolactone
Morel, J. (2018) · theses.fr (ABES) · doi:10.70675/2122074fz09e9z4c6bz84cfzb4d151f34942
Avances clínicos y genéticos en enfermedades renales hereditarias autosómicas dominantes
Furlano, M. M. (2020) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
Modelling molecular mechanisms of polycystic liver disease
Wills, E. S. (2018) · Radboud Repository (Radboud University)
Metadata
- Authors
- Besse, W., Dong, K., Choi, J., Punia, S., Fedeles, S. V., Choi, M., Gallagher, A.-R., Huang, E. B., Gulati, A., Knight, J., Mane, S., Tahvanainen, E., Tahvanainen, P., Sanna-Cherchi, S., Lifton, R. P., Watnick, T., Pei, Y. P., Torres, V. E., & Somlo, S.
- Affiliations
- Yale University (US)
- University of Helsinki (FI)
- University of Maryland, Baltimore (US)
- University Health Network (CA)
- Mayo Clinic (US)
- Corresponding author
- Somlo, Stefan
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2017-04-04
- Volume
- 127
- Issue
- 5
- Pages
- 1772-1785
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5409105
- OpenAlex
- W2605235307
- Cited by
- 203
- References
- 69
- Citations by year
- 2026: 17 · 2025: 14 · 2024: 17 · 2023: 38 · 2022: 25 · 2021: 21 · 2020: 30 · 2019: 13 · 2018: 14 · 2017: 13
- FWCI
- 12.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic (DK090728)
- Yale University
- PKD Australia
- National Institutes of Health (NIH U54, DK090728, UL1TR001863)
- National Human Genome Research Institute (U54HG006504, UM1HG006504)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK100592, R01DK054053, R01DK103184, P30DK090868, R01DK051041, T32DK007276, P30DK079310, R01DK044863, P30DK090728)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- polycystin-1, ALG8, GANAB, PRKCSH, SEC63, PKHD1, autosomal recessive polycystic kidney disease, loss-of-function mutations, liver cysts, genetic heterogeneity
- MeSH terms
- SEC Translocation Channels, Adult, Animals, Calcium-Binding Proteins, Cell Line, Transformed, Cysts, Endoplasmic Reticulum, Female, Glucosidases, Glucosyltransferases, Heterozygote, Humans, Liver Diseases, Male, Membrane Proteins, Mutation, RNA-Binding Proteins, Molecular Chaperones, Intracellular Signaling Peptides and Proteins, TRPP Cation Channels, Mice, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.